|
General Information
|
|
|
Product
|
EHD1 Antibody FITC-Conjugated
|
|
Description
|
FITC-Conjugated EH domain-containing protein 1 Antibody
|
|
Verified Applications
|
ELISA, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human, Mouse, Rat
|
|
Immunogen
|
Synthetic peptide taken wtihin amino acid region 515-565 on human EH-domain containing protein 1.
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.58 µg/µl in antibody stabilization buffer
|
|
Form
|
FITC-Conjugated
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
DB
|
1:10,000
|
|
ELISA
|
1:10,000
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Uniprot #
|
Q9H4M9
|
|
Overview
|
Acts in early endocytic membrane fusion and membrane trafficking of recycling endosomes. Plays a role in myoblast fusion. Recruited to endosomal membranes upon nerve growth factor stimulation, indirectly regulates neurite outgrowth.
|
|
Molecular Function
|
Rab GTPase binding; ATP binding; calcium ion binding
|
|
Subcellular Location
|
Cell membrane, Endosome, Membrane
|
|
Expression
|
testis
|
|
Structure
|
Homooligomer, and heterooligomer with EHD2, EHD3 and EHD4, ATP-binding is required for heterooligomerization.
|
|
Alternative Nomenclature
|
CDABP0131 antibody
EH domain containing 1 antibody
FLJ42622 antibody
FLJ44618 antibody
H PAST antibody
PAST antibody
PAST1 antibody
Testilin antibody
|
|
|
|
EHD1 Antibody
EHD1 Blocking Peptide
EHD1 Antibody BIOTIN
EHD1 Positive Control
